Key Points
- EVP Darby Anderson sold 6,740 Addus HomeCare shares at an average $122.72 each, for about $827,133. After the sale, Anderson held 46,246 shares, a 12.72% reduction in direct ownership.
- Addus reported quarterly earnings of $1.83 per share, topping analysts’ $1.79 estimate, while revenue of $387.74 million came in slightly below forecasts. Revenue grew 7% year over year.
- Analysts’ consensus rating was Moderate Buy, with an average price target of $136.33; recent recommendations ranged from upgrades to Strong Buy to downgrades to Neutral.
Addus HomeCare Corporation (NASDAQ:ADUS - Get Free Report) EVP Cliff Donald Blessing sold 3,499 shares of Addus HomeCare stock in a transaction on Tuesday, November 10th. The shares were sold at an average price of $123.91, for a total transaction of $433,561.09. Following the completion of the transaction, the executive vice president owned 6,684 shares in the company, valued at approximately $828,214.44. This trade represents a 34.36% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.
Cliff Donald Blessing also recently made the following trade(s):
- On Friday, November 6th, Cliff Donald Blessing sold 2,000 shares of Addus HomeCare stock. The shares were sold at an average price of $124.18, for a total transaction of $248,360.00.
Addus HomeCare Stock Down 1.4%
Shares of Addus HomeCare stock opened at $123.72 on Friday. The company has a market cap of $2.30 billion, a P/E ratio of 20.62, a PEG ratio of 1.65 and a beta of 0.75. The company has a debt-to-equity ratio of 0.02, a quick ratio of 1.64 and a current ratio of 1.64. Addus HomeCare Corporation has a one year low of $87.95 and a one year high of $131.59. The firm has a fifty day moving average of $118.30 and a two-hundred day moving average of $107.17.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its earnings results on Tuesday, November 3rd. The company reported $1.83 EPS for the quarter, topping the consensus estimate of $1.79 by $0.04. The company had revenue of $387.74 million during the quarter, compared to analysts' expectations of $388.72 million. Addus HomeCare had a net margin of 7.39% and a return on equity of 10.22%. The business's revenue was up 7.0% on a year-over-year basis. During the same quarter last year, the business earned $1.56 EPS. On average, analysts forecast that Addus HomeCare Corporation will post 6.41 earnings per share for the current year.
Institutional Investors Weigh In On Addus HomeCare
Institutional investors have recently made changes to their positions in the stock. NFJ Investment Group LLC acquired a new position in shares of Addus HomeCare during the 2nd quarter worth $29,000. Heritage Family Offices LLP purchased a new position in shares of Addus HomeCare in the 3rd quarter valued at about $43,000. Parallel Advisors LLC increased its holdings in shares of Addus HomeCare by 66.3% in the 1st quarter. Parallel Advisors LLC now owns 404 shares of the company's stock valued at $38,000 after purchasing an additional 161 shares in the last quarter. Hantz Financial Services Inc. lifted its stake in shares of Addus HomeCare by 21.3% in the third quarter. Hantz Financial Services Inc. now owns 620 shares of the company's stock valued at $69,000 after purchasing an additional 109 shares during the period. Finally, Nisa Investment Advisors LLC lifted its stake in shares of Addus HomeCare by 16.9% in the third quarter. Nisa Investment Advisors LLC now owns 769 shares of the company's stock valued at $85,000 after purchasing an additional 111 shares during the period. 95.35% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
A number of brokerages recently commented on ADUS. UBS Group raised their price objective on shares of Addus HomeCare from $145.00 to $160.00 and gave the company a "buy" rating in a research report on Thursday, November 5th. Weiss Ratings upgraded Addus HomeCare from a "hold (c+)" rating to a "buy (b-)" rating in a research report on Thursday. Citigroup cut Addus HomeCare from a "market outperform" rating to a "neutral" rating in a research report on Monday, September 14th. Zacks Research raised Addus HomeCare from a "hold" rating to a "strong-buy" rating in a research note on Tuesday. Finally, Barclays raised their price target on Addus HomeCare from $96.00 to $101.00 and gave the company an "underweight" rating in a report on Wednesday, November 4th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Addus HomeCare presently has an average rating of "Moderate Buy" and a consensus price target of $136.33.
View Our Latest Stock Report on ADUS
About Addus HomeCare
(
Get Free Report)
Addus HomeCare Corporation provides home-based care services to older adults and people with disabilities. Its services are designed to help clients receive care at home and in other community-based settings. The company operates through personal care, hospice and home health services. Personal care includes assistance with daily activities; hospice provides end-of-life care and support; and home health offers skilled nursing and therapy services. Founded in 1979, Addus serves communities across multiple states.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
